This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Eriya Kenjo: Innovator in Gene Modification Technology
Introduction
Eriya Kenjo is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of gene modification, focusing on enhancing the efficiency of gene delivery techniques. His innovative work has the potential to impact various applications in biotechnology and medicine.
Latest Patents
Eriya Kenjo holds a patent for a composition aimed at modifying target genes. The patent, titled "Composition for modifying target gene," presents a delivery technique that ensures high gene modification efficiency in cells. The composition includes a compound represented by a specific formula, a structural lipid, and a guide RNA or DNA that encodes the guide RNA. This invention is crucial for advancing gene editing technologies.
Career Highlights
Eriya Kenjo is associated with Takeda Pharmaceutical Company Limited, where he applies his expertise in gene modification. His work at Takeda has allowed him to collaborate with leading scientists and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Eriya Kenjo has worked alongside Naoko Fujimoto, a fellow researcher, to further explore the applications of gene modification technologies. Their collaboration has fostered innovative approaches to gene editing and delivery systems.
Conclusion
Eriya Kenjo's contributions to gene modification technology exemplify the importance of innovation in the field of biotechnology. His patent and ongoing work at Takeda Pharmaceutical Company Limited highlight his commitment to advancing scientific research and improving gene delivery methods.